Genmab | Attività Correnti



Current Assets Cambiamento Data
Agios Pharmaceuticals USD 965.6M 108.59M 2024-12
Almirall EUR 693.24M 29.14M 2024-06
Amarin USD 650.22M 51.62M 2024-09
Amgen USD 29.03B 2.26B 2024-12
AstraZeneca USD 25.83B 1.67B 2024-12
Bayer EUR 34.44B 1.31B 2024-12
BioMarin Pharmaceutical USD 3.23B 175.84M 2024-12
Demant DKK 9.92B 731M 2024-12
Exelixis USD 1.47B 82.14M 2025-01
Fresenius Medical Care EUR 7.92B 168.26M 2024-12
Galapagos EUR 3.34B 219.98M 2024-12
Genmab DKK 27.85B 4.16B 2024-12
GlaxoSmithKline GBP 17B 301M 2024-12
GN Store Nord DKK 1.07B 8.14B 2024-12
GRIFOLS EUR 5.73B 404.28M 2024-12
Hikma Pharmaceutical USD 2.28B 185M 2024-06
Insmed USD 1.62B 28.18M 2024-12
Lonza CHF 5.44B 113M 2024-12
Merck EUR 13.93B 882M 2024-09
Novartis USD 29.7B 1.56B 2024-12
Regeneron Pharmaceuticals USD 27.21B 7.88B 2024-12
Roche Holding CHF 40.04B 6.41B 2024-12
Sanofi 30.08B 589M 2024-06
UCB EUR 4.79B 1.47B 2024-12



Genmab Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.